P. Kufer, R. Lutterbüse, and P. Baeuerle, A revival of bispecific antibodies, Trends in Biotechnology, vol.22, issue.5, pp.238-282, 2004.
DOI : 10.1016/j.tibtech.2004.03.006

U. Staerz, O. Kanagawa, and M. Bevan, Hybrid antibodies can target sites for attack by T cells, Nature, vol.157, issue.6012, pp.628-659, 1985.
DOI : 10.1038/314628a0

M. Glennie, H. Mcbride, A. Worth, and G. Stevenson, Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments, J Immunol, vol.139, pp.2367-75, 1987.

G. Behar, S. Sibéril, and A. Groulet, Isolation and characterization of anti-Fc??RIII (CD16) llama single-domain antibodies that activate natural killer cells, Protein Engineering Design and Selection, vol.21, issue.1, pp.1-10, 2008.
DOI : 10.1093/protein/gzm064
URL : https://hal.archives-ouvertes.fr/hal-00258940

D. Müller and R. Kontermann, Recombinant bispecific antibodies for cellular cancer immunotherapy, Curr Opin Mol Ther, vol.9, pp.319-345, 2007.

R. Bargou, E. Leo, and G. Zugmaier, Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody, Science, vol.321, issue.5891, pp.974-981, 2008.
DOI : 10.1126/science.1158545

C. Hamers-casterman, T. Atarhouch, and S. Muyldermans, Naturally occurring antibodies devoid of light chains, Nature, vol.363, issue.6428, pp.446-454, 1993.
DOI : 10.1038/363446a0

A. Willems, S. Schoonooghe, and D. Eeckhout, CD3??????CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation, Cancer Immunology, Immunotherapy, vol.786, issue.1???2, pp.1059-71, 2005.
DOI : 10.1007/s00262-005-0671-8

C. Wu, H. Ying, and C. Grinnell, Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin, Nature Biotechnology, vol.97, issue.11, pp.1290-1297, 2007.
DOI : 10.1038/nbt1345

P. Baeuerle, C. Reinhardt, and P. Kufer, BiTE: A new class of antibodies that recruit T-cells, Drugs of the Future, vol.33, issue.2, pp.137-147, 2008.
DOI : 10.1358/dof.2008.033.02.1172578

L. Doussal, J. Martin, M. Gautherot, and E. , In vitro and in vivo targeting of radiolabeled monovalent and divalent haptens with dual specificity monoclonal antibody conjugates: enhanced divalent hapten affinity for cell-bound antibody conjugate, J Nucl Med, vol.30, pp.1358-66, 1989.

D. Goldenberg, J. Chatal, and J. Barbet, Cancer imaging and therapy with bispecific antibody pretargeting, Update on Cancer Therapeutics, vol.2, issue.1, pp.19-31, 2007.
DOI : 10.1016/j.uct.2007.04.003

D. Goldenberg, E. Rossi, and R. Sharkey, Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting, Journal of Nuclear Medicine, vol.49, issue.1, pp.158-63, 2008.
DOI : 10.2967/jnumed.107.046185

B. Robert, M. Dorvillius, and F. Buchegger, Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA), International Journal of Cancer, vol.75, issue.2, pp.285-91, 1999.
DOI : 10.1002/(SICI)1097-0215(19990412)81:2<285::AID-IJC19>3.0.CO;2-T

M. Dorvillius, V. Garambois, and D. Pourquier, Targeting of Human Breast Cancer by a Bispecific Antibody Directed against Two Tumour-Associated Antigens: ErbB-2 and Carcinoembryonic Antigen, Tumor Biology, vol.23, issue.6, pp.337-384
DOI : 10.1159/000069793

M. Robinson, K. Hodge, and E. Horak, Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro, British Journal of Cancer, vol.5, issue.9, pp.1415-1440, 2008.
DOI : 10.1038/sj.bjc.6604700

D. Lu, H. Zhang, and H. Koo, A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity, Journal of Biological Chemistry, vol.280, issue.20, pp.19665-72, 2005.
DOI : 10.1074/jbc.M500815200

Z. Qu, D. Goldenberg, and T. Cardillo, Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action, Blood, vol.111, issue.4, pp.2211-2220, 2008.
DOI : 10.1182/blood-2007-08-110072